Anti-Gephyrin antibodies: A novel specificity in patients with systemic sclerosis and lower bowel dysfunction is a research paper published in medRxiv (2022). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5K23AR071473-02
Scleroderma and Gastrointestinal Disease: Insights into Clinical Phenotypes and Disease Pathogenesis
National Institutes of Health
Grant: 5R01AG066768-02
Identification of enteric Juvenile Protective Factors and their role in stimulating neurogenesis in the adult and ageing Enteric Nervous System
National Institutes of Health
Grant: 1P30AR070254-01
Johns Hopkins Rheumatic Diseases Resource-based Core Center
National Institutes of Health
Grant: 1S10OD025244-01
Olympus FluoView3000RS Confocal Microscope
National Institutes of Health
Grant: 5R01AR073208-04
Autoantibodies Define Scleroderma Subgroups with Distinct Relationships to Cancer
National Institutes of Health
Grant: 5R01AR069569-04
The role of complement citrullination in RA pathogenesis
Fields of Study
Keywords
Sustainable Development Goals